The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...
The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for ...
GLP-1 drugs like Ozempic became so popular as weight loss drugs that there was a mid-year shortage. These drugs are also ...